Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Makoto Hiraide"'
Autor:
Atsunobu Sagara, Akihito Nagahama, Hayato Aki, Hiroki Yoshimura, Makoto Hiraide, Takatsune Shimizu, Motohiko Sano, Tetsuro Yumoto, Tomoo Hosoe, Kenji Tanaka
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 10, Iss 1, Pp 1-9 (2024)
Abstract Background Concerns persist regarding the potential reduction in driving performance due to taking second-generation antihistamines or performing hands-free calling. Previous studies have indicated a potential risk to driving performance und
Externí odkaz:
https://doaj.org/article/1a9d4ef7ad6640d9b4ef832d753e10f3
Autor:
Takeshi Aoyama, Kenji Nakano, Takeshi Yuasa, Erika Sugiyama, Takako Okawa, Kazuyuki Ito, Keiichi Azuma, Koki Hashimoto, Ryota Furutani, Makoto Hiraide, Kazuo Kobayashi, Kenichi Suzuki, Jyunnichi Tomomatsu, Masataka Tajima, Hitoshi Sato, Toshihiro Hama, Shunji Takahashi
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract The safety and effectiveness of pazopanib are related to plasma trough concentrations in renal cell carcinoma (RCC); however, data on pazopanib plasma trough concentrations with soft tissue sarcoma (STS) are limited. This study investigated
Externí odkaz:
https://doaj.org/article/980b2c0f97b242018c4d72bbb6d25e96
Autor:
Yusuke Iikura, Takeshi Aoyama, Makoto Hiraide, Takeru Wakatsuki, Izuma Nakayama, Mariko Ogura, Akira Ooki, Daisuke Takahari, Keisho Chin, Kensei Yamaguchi, Toshihiro Hama
Publikováno v:
Health Science Reports, Vol 5, Iss 4, Pp n/a-n/a (2022)
Abstract Background and Aims This study aimed to examine the safety of fixed‐dose nivolumab. Methods We retrospectively reviewed the medical records of 113 Japanese patients with gastric cancer who were previously treated with cytotoxic chemotherap
Externí odkaz:
https://doaj.org/article/b2b34521a95d4e6aad402f4e1d4af7b9
Autor:
Atsunobu Sagara, Akihito Nagahama, Hayato Aki, Hiroki Yoshimura, Makoto Hiraide, Takatsune Shimizu, Motohiko Sano, Tetsuro Yumoto, Tomoo Hosoe, Kenji Tanaka
Publikováno v:
Traffic Injury Prevention; 2024, Vol. 25 Issue 1, p36-40, 5p
Autor:
Hitoshi Sato, Makoto Hiraide, Takeshi Aoyama, Yusuke Iikura, Kenichi Suzuki, Koki Hashimoto, Erika Sugiyama, Kazuo Kobayashi, Toshihiro Hama, Takashi Yokokawa, Masataka Tajima, Sari Shikibu
Publikováno v:
In Vivo
Background/Aim: Immune-related adverse events (irAEs) are associated with the efficacy of immune-checkpoint inhibitors in patients with melanoma and non-small cell lung cancer. We therefore evaluated the relationship between irAEs and nivolumab effic
Autor:
Yusuke Iikura, Takeshi Aoyama, Makoto Hiraide, Takeru Wakatsuki, Izuma Nakayama, Mariko Ogura, Akira Ooki, Daisuke Takahari, Keisho Chin, Kensei Yamaguchi, Toshihiro Hama
Publikováno v:
Health science reports. 5(4)
This study aimed to examine the safety of fixed-dose nivolumab.We retrospectively reviewed the medical records of 113 Japanese patients with gastric cancer who were previously treated with cytotoxic chemotherapy and initiated nivolumab. The endpoints
Autor:
Kazuo Kobayashi, Naoki Shibata, Yusuke Yamahata, Shuhei Ban, Toshihiro Hama, Makoto Hiraide, Keiichi Azuma
Publikováno v:
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 45:584-590
Autor:
Takuya, Tomomatsu, Makoto, Hiraide, Takeshi, Aoyama, Kenichi, Suzuki, Yoshinori, Ito, Toshihiro, Hama
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 47(10)
This retrospective study aimed to evaluate the effect of the antiemetic drug olanzapine(OLZ)on blood sugar levels in patients treated with adjuvant or neoadjuvant chemotherapy(AC: doxorubicin plus cyclophosphamide or CEF: cyclophosphamide plus epirub
Autor:
Taro Shiga, Makoto Hiraide
Publikováno v:
Current Treatment Options in Oncology
Opinion statementFluoropyrimidine (FP) is used to treat a wide range of cancers; however, it is associated with drug-induced vascular toxicity, as well as angina pectoris and coronary spasm. FP has been administered for many years, although the incid
Autor:
Takeshi Aoyama, Takashi Tsunoda, Ryota Furutani, Kazuyoshi Kawakami, Kazuyuki Ito, Kensei Yamaguchi, Hiroki Kato, Kazuo Kobayashi, Takashi Ichimura, Akane Hagino, Masashi Nakamura, Kenichi Suzuki, Hidenori Yoshioka, Toshihiro Hama, Makoto Hiraide
Publikováno v:
Journal of chemotherapy (Florence, Italy). 32(3)
Although a short hydration protocol for cisplatin has been recently developed for use in lung cancer, this has yet to be established for gastric cancer. This study reviewed medical records of patients with gastric cancer who received XPT(capecitabine